{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:42:58Z","timestamp":1793882578711,"version":"4.7.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T00:00:00Z","timestamp":1510272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T00:00:00Z","timestamp":1510272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Acinetobacter baumannii<\/jats:italic> has been a dreadful problem for ICU physicians for a long time. Bacteremic pneumonia (BP) caused by this organism has a higher mortality compared to other organisms. Between 2012 and 2015, 86 BP and 89 non-bacteremic pneumonia (NBP) patients from five ICUs were enrolled into the study. The 7-day and 14-day mortality rates were higher in BP patients than in NBP patients (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Procalcitonin elevation, high APACHEII score and recent surgery, were independently associated with BP episodes. Acute respiratory distress syndrome, coma, high APACHEII score and procalcitonin elevation, were independently associated with mortality in the BP group. Extensively drug-resistant isolates were detected in 34.9% of BP and 25.8% of NBP isolates. PFGE identified 12 and 9 genotypes in the BP and NBP isolates, respectively, with 6 genotypes shared by both groups. ST195 was the most prevalent type (40%), followed by ST457 (18.9%). The pandemic clonal complex 92 was predominant, accounting for 94.3% of the strains. For all studied periods, mortality remained higher in the BP than the NBP group. Disease severity was the main risk factor for high mortality in the BP group, and other factors related to mortality were infection, and not treatment or microbiology-related.<\/jats:p>","DOI":"10.1038\/s41598-017-13148-y","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T10:50:57Z","timestamp":1509965457000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Bacteremic and non-bacteremic pneumonia caused by Acinetobacter baumannii in ICUs of South China: A Clinical and Microbiological Study"],"prefix":"10.1038","volume":"7","author":[{"given":"Yunfang","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Kudinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Akova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3640-6518","authenticated-orcid":false,"given":"Chao","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,10]]},"reference":[{"key":"13148_CR1","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1586\/14787210.2015.1032254","volume":"13","author":"J Garnacho-Montero","year":"2015","unstructured":"Garnacho-Montero, J. et al. Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia. Expert Rev Anti Infect Ther \n                           13, 769\u2013777 (2015).","journal-title":"Expert Rev Anti Infect Ther"},{"key":"13148_CR2","doi-asserted-by":"publisher","first-page":"402","DOI":"10.5455\/medarh.2014.68.402-406","volume":"68","author":"A Custovic","year":"2014","unstructured":"Custovic, A. et al. Epidemiological monitoring of nosocomial infections caused by Acinetobacter baumannii. Med Arch \n                           68, 402\u2013406 (2014).","journal-title":"Med Arch"},{"key":"13148_CR3","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1164\/rccm.201102-0349OC","volume":"184","author":"DR Chung","year":"2011","unstructured":"Chung, D. R. et al. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. Am J Respir Crit Care Med \n                           184, 1409\u20131417 (2011).","journal-title":"Am J Respir Crit Care Med"},{"key":"13148_CR4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.cmi.2015.09.015","volume":"22","author":"A Xu","year":"2016","unstructured":"Xu, A. et al. National epidemiology of carbapenem-resistant and extensively drug-resistant Gram-negative bacteria isolated from blood samples in China in 2013. Clin Microbiol Infec \n                           22, S1\u2013S8 (2016).","journal-title":"Clin Microbiol Infec"},{"key":"13148_CR5","doi-asserted-by":"crossref","unstructured":"Pogue, J. M., Mann, T., Barber, K. E. & Kayr, K. S. Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management. Expert Rev Anti-Infe, 383\u2013393 (2013).","DOI":"10.1586\/eri.13.14"},{"key":"13148_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jmii.2014.06.011","volume":"48","author":"S Teng","year":"2015","unstructured":"Teng, S. et al. Comparison of pneumonia- and non-pneumonia-related Acinetobacter baumannii bacteremia: Impact on empiric therapy and antibiotic resistance. Journal of Microbiology, Immunology and Infection \n                           48, 525\u2013530 (2015).","journal-title":"Journal of Microbiology, Immunology and Infection"},{"key":"13148_CR7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1001\/jama.230.4.558","volume":"230","author":"P Iannini","year":"1974","unstructured":"Iannini, P., Claffey, T. & Quintiliani, R. Bacteremic Pseudomonas pneumonia. JAMA \n                           230, 558\u2013561 (1974).","journal-title":"JAMA"},{"key":"13148_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1086\/421946","volume":"39","author":"H Wisplinghoff","year":"2004","unstructured":"Wisplinghoff, H. et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis \n                           39, 309\u2013317 (2004).","journal-title":"Clin Infect Dis"},{"key":"13148_CR9","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/1469-0691.12363","volume":"20","author":"EV Lemos","year":"2014","unstructured":"Lemos, E. V. et al. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis. Clin Microbiol Infect \n                           20, 416\u2013423 (2014).","journal-title":"Clin Microbiol Infect"},{"key":"13148_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jhin.2009.06.007","volume":"73","author":"TN Jang","year":"2009","unstructured":"Jang, T. N., Lee, S. H., Huang, C. H., Lee, C. L. & Chen, W. Y. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study. J Hosp Infect \n                           73, 143\u2013150 (2009).","journal-title":"J Hosp Infect"},{"key":"13148_CR11","doi-asserted-by":"publisher","first-page":"e811","DOI":"10.1016\/j.ijid.2012.07.006","volume":"16","author":"W Punpanich","year":"2012","unstructured":"Punpanich, W., Nithitamsakun, N., Treeratweeraphong, V. & Suntarattiwong, P. Risk factors for carbapenem non-susceptibility and mortality in Acinetobacter baumannii bacteremia in children. Int J Infect Dis \n                           16, e811\u2013e815 (2012).","journal-title":"Int J Infect Dis"},{"key":"13148_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/sj.bmt.1705561","volume":"39","author":"E Meyer","year":"2007","unstructured":"Meyer, E. et al. Risk factor analysis of blood stream infection and pneumonia in neutropenic patients after peripheral blood stem-cell transplantation. Bone Marrow Transplant \n                           39, 173\u2013178 (2007).","journal-title":"Bone Marrow Transplant"},{"key":"13148_CR13","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00134-015-4079-4","volume":"41","author":"J Garnacho-Montero","year":"2015","unstructured":"Garnacho-Montero, J. et al. Task force on management and prevention of Acinetobacter baumannii infections in the ICU. Intensive Care Med \n                           41, 2057\u20132075 (2015).","journal-title":"Intensive Care Med"},{"key":"13148_CR14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1086\/526775","volume":"46","author":"KB Anthony","year":"2008","unstructured":"Anthony, K. B. et al. Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline. Clin Infect Dis \n                           46, 567\u2013570 (2008).","journal-title":"Clin Infect Dis"},{"key":"13148_CR15","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1128\/AAC.01232-12","volume":"57","author":"J Ramirez","year":"2013","unstructured":"Ramirez, J. et al. Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia. Antimicrob Agents Ch \n                           57, 1756\u20131762 (2013).","journal-title":"Antimicrob Agents Ch"},{"key":"13148_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s15010-011-0187-4","volume":"40","author":"MC Chiang","year":"2012","unstructured":"Chiang, M. C. et al. Clinical characteristics and outcomes of bacteremia due to different genomic species of Acinetobacter baumannii complex in patients with solid tumors. Infection \n                           40, 19\u201326 (2012).","journal-title":"Infection"},{"key":"13148_CR17","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ijantimicag.2013.06.019","volume":"42","author":"Z Ruan","year":"2013","unstructured":"Ruan, Z. et al. Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China. Int J Antimicrob Ag \n                           42, 322\u2013328 (2013).","journal-title":"Int J Antimicrob Ag"},{"key":"13148_CR18","unstructured":"Institue, C.A.L.S. Performance standards forantimicrobial susceptibility testing; nineteenth informational supplement.ment. CLSI document M100\u2013 S23. Clinical and Laboratory Standards Institute (2013)."},{"key":"13148_CR19","volume":"10","author":"Q Liu","year":"2015","unstructured":"Liu, Q. et al. Risk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West China. PLoS One \n                           10, e130701 (2015).","journal-title":"PLoS One"},{"key":"13148_CR20","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.cmi.2015.12.010","volume":"22","author":"MP Freire","year":"2016","unstructured":"Freire, M. P. et al. Bloodstream infection caused by extensively drug-resistant Acinetobacter baumannii in cancer patients: high mortality associated with delayed treatment rather than with the degree of neutropenia. Clin Microbiol Infec \n                           22, 352\u2013358 (2016).","journal-title":"Clin Microbiol Infec"},{"key":"13148_CR21","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s10096-014-2281-x","volume":"34","author":"VC Cheng","year":"2015","unstructured":"Cheng, V. C. et al. Control of hospital endemicity of multiple-drug-resistant Acinetobacter baumannii ST457 with directly observed hand hygiene. Eur J Clin Microbiol Infect Dis \n                           34, 713\u2013718 (2015).","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"13148_CR22","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil, A. C. et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis \n                           63, e61\u2013e111 (2016).","journal-title":"Clin Infect Dis"},{"key":"13148_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/cid\/cis385","volume":"55","author":"YT Lee","year":"2012","unstructured":"Lee, Y. T. et al. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection. Clin Infect Dis \n                           55, 209\u2013215 (2012).","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"13148_CR24","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.cmi.2015.11.004","volume":"22","author":"X Guan","year":"2016","unstructured":"Guan, X. et al. Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement. Clin Microbiol Infect \n                           22(Suppl 1), S15\u2013S25 (2016).","journal-title":"Clin Microbiol Infect"},{"key":"13148_CR25","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/jac\/dkq027","volume":"65","author":"Y Fu","year":"2010","unstructured":"Fu, Y. et al. Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China. J Antimicrob Chemoth \n                           65, 644\u2013650 (2010).","journal-title":"J Antimicrob Chemoth"},{"key":"13148_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos, A. P. et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infec \n                           18, 268\u2013281 (2012).","journal-title":"Clin Microbiol Infec"},{"key":"13148_CR27","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1128\/jcm.33.5.1402-1407.1995","volume":"33","author":"H Seifert","year":"1995","unstructured":"Seifert, H. & Gerner-Smidt, P. Comparison of ribotyping and pulsed-field gel electrophoresis for molecular typing of Acinetobacter isolates. J Clin Microbiol \n                           33, 1402\u20131407 (1995).","journal-title":"J Clin Microbiol"},{"key":"13148_CR28","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/jcm.33.9.2233-2239.1995","volume":"33","author":"FC Tenover","year":"1995","unstructured":"Tenover, F. C. et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol \n                           33, 2233\u20132239 (1995).","journal-title":"J Clin Microbiol"},{"key":"13148_CR29","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1128\/JCM.43.9.4382-4390.2005","volume":"43","author":"SG Bartual","year":"2005","unstructured":"Bartual, S. G. et al. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol \n                           43, 4382\u20134390 (2005).","journal-title":"J Clin Microbiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13148-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13148-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13148-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T13:26:25Z","timestamp":1671801985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13148-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,10]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["13148"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-13148-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,10]]},"assertion":[{"value":"17 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15279"}}